ImClone Closing Branchburg, New Jersey Manufacturing Facility
08/17/2010
"This decision was made after careful consideration of a number of internal and external factors related to Erbitux [a cancer drug]," said Janice Chavers, an Eli Lilly spokesperson. "The decision was not driven by Lilly's larger restructuring effort."
ImClone currently has 90 open positions for which employees affected by the layoffs will have priority. The closure plans are effective immediately.
Project Announcements
Walmart Plans Upgrades Cullman, Alabama, Regional Distribution Hub
06/08/2023
Silver Branch Brewing Establishes Fauquier County, Virginia, Operations
06/08/2023
Protego (USA) Expands North Charleston, South Carolina, Operations
06/08/2023
South Korea-Based INFAC North America Expands Campbellsville, Kentucky, Operations
06/08/2023
Applied Physics Technologies Expands McMinnville, Oregon, Operations
06/02/2023
Bosch Expands Lincolnton, North Carolina, Operations
06/02/2023
Most Read
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023
-
Is a Flurry of Fads Shaping Economic Development Policy?
Q2 2023
-
EV and Semiconductor Projects Stand Out in States Receiving Area Development’s 18th Annual Shovel Awards
Q2 2023
-
Life Science Conversions in Real Estate
Q2 2023
-
Front Line: Water Supply Increasingly Affecting Location Decisions
Q2 2023
-
Nearshoring — North America’s Next Factory
Q2 2023
-
First Person: Labor Crunch in the Construction Industry
Q2 2023